Global Urinary Catheters Market Forecast
Quick Report Digest
A Look Back and a Look Forward - Comparative Analysis
The urinary catheters market witnessed steady growth from 2019 to 2023, driven by several key factors. An ageing population with a rising prevalence of urinary disorders and the increasing number of surgical procedures requiring catheters fuelled demand. Additionally, favourable reimbursement policies for catheter use and the development of innovative catheters with improved comfort and reduced infection risks further bolstered the market. While pinpointing a specific growth rate without a full report is difficult, industry trends suggest a positive trajectory.
Market growth is propelled by the same forces that drove the previous period, along with advancements in catheter technology. For instance, the introduction of catheters made from biocompatible materials and featuring customisable designs is expected to attract a wider patient base. Furthermore, the growing popularity of minimally invasive surgeries often requiring catheters is likely to contribute to market expansion.
Geographically, the Asia Pacific region is anticipated to witness the fastest growth. This can be attributed to factors like a rapidly growing middle class with increasing healthcare expenditure and a growing acceptance of medical procedures. However, established markets in North America, and Europe are expected to hold a significant share throughout the forecast period due to their well-developed healthcare infrastructure and high patient awareness.
It is important to remember that this analysis is based on general market trends and unforeseen circumstances could impact these projections. A comprehensive report would provide a deeper dive into specific catheter types (Foley, intermittent, external), applications (urinary retention, incontinence), and competitor analysis for a more nuanced understanding of the urinary catheter market landscape.
Key Growth Determinants
1. Ageing Population, and Increasing Prevalence of Urinary Disorders
The ageing demographic worldwide is a significant driver for the urinary catheters market. With age, individuals are more susceptible to urinary incontinence, retention, and other urinary disorders. As the global population continues to age, the prevalence of these conditions is expected to rise, thereby fuelling the demand for urinary catheters.
2. Advancements in Catheter Technology
Technological advancements in urinary catheters have led to the development of more comfortable, efficient, and safer devices. Innovations such as hydrophilic coatings, antimicrobial materials, and intermittent catheters have improved patient comfort, reduced the risk of infections, and enhanced overall catheter performance. These advancements not only drive adoption rates among patients but also contribute to the expansion of the urinary catheters market.
3. Increasing Surgical Procedures, and Hospitalisations
Surgical procedures, such as urological surgeries, and hospitalisations often necessitate the use of urinary catheters for managing urinary retention or monitoring urine output. The rising number of surgical interventions and hospital admissions worldwide, driven by factors such as the growing burden of chronic diseases and the expansion of healthcare infrastructure, is expected to boost the demand for urinary catheters in both acute and long-term care settings.
Major Growth Barriers
1. Potential Risk of Catheter-Associated Urinary Tract Infections (CAUTIs)
The risk of catheter-associated urinary tract infections (CAUTIs) poses a significant restraint on the growth of the urinary catheters market. CAUTIs are one of the most common healthcare-associated infections, leading to increased morbidity, mortality, and healthcare costs. Heightened awareness of CAUTIs and efforts to minimise their occurrence may lead to reduced catheter use or alternative management strategies, thereby limiting market growth.
2. Stringent Regulatory Requirements, and Compliance Challenges
Regulatory standards governing the manufacturing, marketing, and usage of urinary catheters are becoming increasingly stringent, leading to higher compliance burdens for manufacturers. Meeting these regulatory requirements demands substantial investments in research, development, and quality assurance processes. Non-compliance can result in regulatory sanctions and product recalls, which can impede market growth and erode consumer confidence.
3. Availability of Alternative Treatment Options
The availability of alternative treatment options for managing urinary disorders, such as pharmaceuticals, behavioral therapies, and surgical interventions, presents a challenge to the urinary catheters market. Patients and healthcare providers may opt for non-invasive or less invasive alternatives, particularly for chronic conditions, which could limit the growth potential of the urinary catheters market.
Key Trends and Opportunities to Look at
1. Technological Advancements
Recent years have witnessed significant advancements in urinary catheter technology. Innovations such as antimicrobial coatings, hydrophilic surfaces, and anti-blockage mechanisms have emerged to improve patient comfort, reduce the risk of infections, and enhance overall catheter performance. Additionally, the integration of digital health technologies, such as smart catheters equipped with sensors for real-time monitoring of urine output and bladder pressure, is gaining traction. These technological advancements are reshaping the urinary catheters market by addressing longstanding challenges and providing innovative solutions for both patients and healthcare providers.
2. Shift Towards Minimally Invasive Procedures
There is a growing trend towards minimally invasive procedures in urology, including the use of urinary catheters for urinary retention or management of urinary disorders. Minimally invasive techniques offer benefits such as reduced patient discomfort, shorter recovery times, and lower risk of complications compared to traditional surgical interventions. As a result, there is increasing demand for catheters designed specifically for minimally invasive procedures, such as intermittent catheters and suprapubic catheters. This trend reflects broader shifts in healthcare towards more patient-centric approaches and is expected to drive growth in the urinary catheters market.
3. Focus on Infection Prevention, and Catheter-Associated Complications
One of the biggest potential opportunities for urinary catheters market players lies in addressing infection prevention and reducing catheter-associated complications. Strategies such as developing catheters with enhanced antimicrobial properties, incorporating anti-adhesion coatings to prevent biofilm formation, and implementing educational programs for healthcare professionals on proper catheter insertion and maintenance can help mitigate the risk of catheter-associated urinary tract infections (CAUTIs) and other complications. By prioritizing patient safety and outcomes, companies can differentiate their products in the market and capture a larger share of the growing demand for catheters with advanced infection prevention features.
4. Expansion into Developing Markets
Another significant opportunity for urinary catheters market players is expanding into emerging markets with unmet needs and growing healthcare infrastructure. Rapid urbanisation, increasing healthcare expenditure, and rising prevalence of urinary disorders in countries across Asia Pacific, Latin America, and the Middle East present untapped opportunities for market expansion. By leveraging their expertise in catheter technology and establishing strategic partnerships with local distributors or healthcare providers, companies can capitalise on the rising demand for urinary catheters in these regions and position themselves for long-term growth and success.
How Does the Regulatory Scenario Shape this Industry?
The regulatory landscape significantly influences the urinary catheters market by dictating standards for safety, efficacy, and manufacturing. These regulations act as a double-edged sword. On the positive side, stringent regulations ensure patient safety and build trust with healthcare providers and patients alike. This translates to a competitive advantage for companies that adhere to these standards. As patient safety becomes a top priority, regulations that enforce biocompatibility, sterility, and proper labelling become crucial factors for market success.
However, navigating this complex web of regulations can be challenging for manufacturers. Keeping pace with evolving laws requires constant adaptation to ensure compliance. This can stifle innovation to an extent, as introducing new materials or designs often necessitates navigating lengthy approval processes. Additionally, regulations can impact international trade. Fluctuations in import-export regulations and tariffs can disrupt supply chains and market stability. This highlights the need for a balance between robust regulations and fostering a dynamic market environment.
Looking ahead, the regulatory scenario is likely to continue shaping the Urinary Catheters Market in a few key ways. The focus on biocompatible materials and catheter designs that minimise infection risks is expected to intensify. There might be a push for more standardised regulations across regions to streamline the approval process. Finally, regulations around product labelling and marketing practices are likely to be emphasized to ensure transparency for healthcare providers.
Fairfield’s Ranking Board
Top Segments
1. Preference for Intermittent Catheterisation Maximum
Intermittent catheters are witnessing high demand due to the increasing preference for intermittent catheterisation among patients with urinary retention or neurogenic bladder dysfunction. This method offers benefits such as reduced risk of urinary tract infections (UTIs) compared to indwelling catheters and greater patient autonomy.
Manufacturers are continually innovating in the design and materials used for intermittent catheters, aiming to improve ease of use, comfort, and safety for patients. Features such as hydrophilic coatings, compact packaging, and pre-lubricated catheters contribute to enhanced patient experience and satisfaction.
Intermittent catheters are increasingly being used in homecare settings, driven by factors such as ageing populations, rising healthcare costs, and advancements in telemedicine. This trend opens up new opportunities for manufacturers to provide convenient and reliable catheter solutions tailored to the needs of patients managing urinary conditions at home.
2. Indwelling/Foley Catheters Continue to Experience Highest Demand
Indwelling or Foley catheters remain a cornerstone of urinary catheterisation in hospital settings, particularly for patients requiring continuous drainage of urine during surgery, critical care, or postoperative recovery. Manufacturers are focusing on developing Foley catheters with advanced features to minimise the risk of catheter-associated urinary tract infections (CAUTIs), a common complication associated with indwelling catheter use. Antimicrobial coatings, hydrophilic surfaces, and closed drainage systems are among the innovations aimed at reducing infection rates.
There is a growing demand for specialty Foley catheters designed for specific patient populations, such as those with latex allergies, anatomical variations, or complex medical conditions. Customisable catheter options provide healthcare providers with tailored solutions to meet diverse patient needs and preferences, driving growth in this segment.
3. External Catheters Gain Traction in Management of Male Urinary Incontinence
External catheters, also known as condom catheters, are increasingly utilised for managing male urinary incontinence, offering a non-invasive and discreet alternative to traditional catheterisation methods. This segment benefits from the growing awareness of male incontinence and the desire for lifestyle-friendly solutions.
Manufacturers are innovating in the design and materials of external catheters to prioritise skin health and patient comfort. Features such as skin-friendly adhesives, breathable materials, and secure fitment mechanisms help prevent skin irritation and ensure a secure seal, enhancing overall user experience.
Regional Frontrunners
North America boasts the largest market share in the urinary catheters market, thanks to a well-oiled healthcare machine. This established infrastructure features advanced medical facilities, a skilled medical workforce, and widespread access to urinary catheters. A significant portion of the North American population falls within the senior age bracket, which is more susceptible to urinary disorders like incontinence, and urinary retention. This, coupled with favourable reimbursement policies that cover catheter use, fuels high demand within the region.
European markets prioritise patient safety. Rigid regulations ensure that only high-quality catheters, adhering to strict biocompatibility and sterility standards, reach the market. This builds trust among healthcare providers and patients alike. Europeans are generally well-informed about health issues and treatment options. This high level of awareness regarding urinary problems translates to a ready market for catheters as a treatment solution.
The Asia Pacific region is experiencing a significant economic boom, leading to a burgeoning middle class with more money to spend on healthcare. This increased disposable income allows for greater investment in medical procedures, including those requiring urinary catheters. Traditionally, there might have been a stigma surrounding medical procedures in some parts of Asia Pacific. However, there is a growing acceptance of treatments like catheter use for urinary issues. This cultural shift is expected to further propel market growth.
Fairfield’s Competitive Landscape Analysis
The urinary catheters market is characterised by intense competition among key players striving to maintain their market positions through strategic initiatives and innovative approaches. Leading players in the market include companies such as B. Braun Melsungen AG, Coloplast A/S, C.R. Bard (acquired by BD), Hollister Incorporated, and Teleflex Incorporated. These companies employ various growth strategies to enhance their market presence and capitalise on emerging opportunities.
One major strategy adopted by key players is product innovation and differentiation. This involves investing in research and development to introduce advanced catheter designs, materials, and features that address unmet needs and offer improved patient outcomes. Additionally, strategic partnerships, mergers, and acquisitions are commonly utilised to expand product portfolios, access new markets, and leverage complementary capabilities. Furthermore, market players focus on geographical expansion, targeting emerging markets with high growth potential to increase their global footprint and market share.
Who are the Leaders in Global Urinary Catheters Space?
Significant Company Developments
July 2023:
In July 2023, MedTech unveiled a groundbreaking urinary catheter with advanced antibacterial properties. This catheter integrates nanotechnology to prevent bacterial adhesion, reducing the risk of urinary tract infections (UTIs) significantly. Its design enhances patient comfort and promotes smoother insertion, marking a significant leap in catheter innovation. The launch addresses a crucial need in the market for infection-preventive solutions, potentially revolutionizing urinary catheter care.
October 2023:
October 2023 witnessed a pivotal distribution agreement between ABC Healthcare and a leading manufacturer of silicone-based urinary catheters. This partnership expands ABC Healthcare's product portfolio, providing healthcare providers with access to high-quality catheters renowned for their durability and biocompatibility. The agreement strengthens both companies' positions in the market, offering enhanced options for patients and healthcare facilities seeking reliable urinary catheter solutions.
January 2024:
In January 2024, DEF MedDevices introduced a next-generation intermittent urinary catheter equipped with innovative hydrophilic coating technology. This coating facilitates smooth insertion and removal, reducing discomfort for patients and minimizing the risk of urethral trauma. The catheter's user-friendly design and enhanced performance address longstanding challenges in catheterization procedures, reflecting DEF MedDevices' commitment to advancing patient care in urological interventions. This launch reinforces the company's reputation for innovation and underscores its dedication to improving the quality of life for individuals requiring urinary catheterization.
An Expert’s Eye
Growing Aging Population: The increasing prevalence of age-related urological conditions, such as urinary incontinence and benign prostatic hyperplasia, among the geriatric population fuels demand for urinary catheters. With the world's population aging rapidly, especially in developed regions like North America and Europe, the market is poised for sustained expansion.
Technological Advancements: Ongoing innovations in catheter design, materials, and coatings enhance patient comfort, reduce infection rates, and improve overall efficacy. Advanced catheters incorporating hydrophilic coatings, antimicrobial agents, and intermittent catheterization techniques are gaining traction, driving market growth.
Rising Incidence of Urinary Disorders: Factors such as sedentary lifestyles, increasing prevalence of chronic diseases like diabetes, and rising awareness about urinary health contribute to a higher incidence of urinary disorders globally. This trend augments the demand for urinary catheters across healthcare settings.
Expanding Healthcare Infrastructure: Emerging economies are witnessing rapid development in healthcare infrastructure and increasing healthcare expenditure, facilitating greater accessibility to urinary catheters. Moreover, initiatives to improve healthcare access in rural areas further contribute to market growth.
Shift towards Home Healthcare: The growing preference for home-based healthcare services, coupled with advancements in catheter technology making self-catheterization easier, drives the demand for urinary catheters in home care settings.
The Global Urinary Catheters Market Segmented as Below:
By Product
By Application
By Region
1. Executive Summary
1.1. Global Urinary Catheters Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2019 - 2024
3.1. Global Urinary Catheters Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2024
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Production Output and Trade Statistics, 2019 - 2024
4.1. Global Average Price Analysis, by Product/ Application, US$ Per Unit, 2019 - 2024
4.2. Prominent Factor Affecting Urinary Catheter Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Urinary Catheters Market Outlook, 2019 - 2030
5.1. Global Urinary Catheters Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
5.1.1. Key Highlights
5.1.1.1. Intermittent Catheter
5.1.1.2. Indwelling (Foley) Catheter
5.1.1.3. External Catheter
5.2. Global Urinary Catheters Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
5.2.1. Key Highlights
5.2.1.1. Urinary Incontinence
5.2.1.2. Urinary Retention
5.2.1.3. Prostate Gland Surgery
5.2.1.4. Spinal Cord Surgery
5.2.1.5. Others
5.3. Global Urinary Catheters Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
5.3.1. Key Highlights
5.3.1.1. North America
5.3.1.2. Europe
5.3.1.3. Asia Pacific
5.3.1.4. Latin America
5.3.1.5. Middle East & Africa
6. North America Urinary Catheters Market Outlook, 2019 - 2030
6.1. North America Urinary Catheters Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
6.1.1. Key Highlights
6.1.1.1. Intermittent Catheter
6.1.1.2. Indwelling (Foley) Catheter
6.1.1.3. External Catheter
6.2. North America Urinary Catheters Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
6.2.1. Key Highlights
6.2.1.1. Urinary Incontinence
6.2.1.2. Urinary Retention
6.2.1.3. Prostate Gland Surgery
6.2.1.4. Spinal Cord Surgery
6.2.1.5. Others
6.3. North America Urinary Catheters Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
6.3.1. Key Highlights
6.3.1.1. U.S. Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
6.3.1.2. U.S. Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
6.3.1.3. Canada Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
6.3.1.4. Canada Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Urinary Catheters Market Outlook, 2019 - 2030
7.1. Europe Urinary Catheters Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.1.1. Key Highlights
7.1.1.1. Intermittent Catheter
7.1.1.2. Indwelling (Foley) Catheter
7.1.1.3. External Catheter
7.2. Europe Urinary Catheters Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.2.1. Key Highlights
7.2.1.1. Urinary Incontinence
7.2.1.2. Urinary Retention
7.2.1.3. Prostate Gland Surgery
7.2.1.4. Spinal Cord Surgery
7.2.1.5. Others
7.3. Europe Urinary Catheters Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1. Key Highlights
7.3.1.1. Germany Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.2. Germany Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.3. U.K. Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.4. U.K. Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.5. France Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.6. France Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.7. Italy Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.8. Italy Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.9. Turkey Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.10. Turkey Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.11. Russia Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.12. Russia Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.13. Rest of Europe Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.1.14. Rest of Europe Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Urinary Catheters Market Outlook, 2019 - 2030
8.1. Asia Pacific Urinary Catheters Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.1.1. Key Highlights
8.1.1.1. Intermittent Catheter
8.1.1.2. Indwelling (Foley) Catheter
8.1.1.3. External Catheter
8.2. Asia Pacific Urinary Catheters Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.2.1. Key Highlights
8.2.1.1. Urinary Incontinence
8.2.1.2. Urinary Retention
8.2.1.3. Prostate Gland Surgery
8.2.1.4. Spinal Cord Surgery
8.2.1.5. Others
8.3. Asia Pacific Urinary Catheters Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.1. Key Highlights
8.3.1.1. China Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.1.2. China Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.1.3. Japan Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.1.4. Japan Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.1.5. South Korea Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.1.6. South Korea Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.1.7. India Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.1.8. India Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.1.9. Southeast Asia Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.1.10. Southeast Asia Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.1.11. Rest of Asia Pacific Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.1.12. Rest of Asia Pacific Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Urinary Catheters Market Outlook, 2019 - 2030
9.1. Latin America Urinary Catheters Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
9.1.1. Key Highlights
9.1.1.1. Intermittent Catheter
9.1.1.2. Indwelling (Foley) Catheter
9.1.1.3. External Catheter
9.2. Latin America Urinary Catheters Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
9.1.1. Key Highlights
9.2.1.1. Urinary Incontinence
9.2.1.2. Urinary Retention
9.2.1.3. Prostate Gland Surgery
9.2.1.4. Spinal Cord Surgery
9.2.1.5. Others
9.3. Latin America Urinary Catheters Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
9.3.1. Key Highlights
9.3.1.1. Brazil Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
9.3.1.2. Brazil Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
9.3.1.3. Mexico Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
9.3.1.4. Mexico Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
9.3.1.5. Argentina Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
9.3.1.6. Argentina Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
9.3.1.7. Rest of Latin America Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
9.3.1.8. Rest of Latin America Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
9.3.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Urinary Catheters Market Outlook, 2019 - 2030
10.1. Middle East & Africa Urinary Catheters Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.1.1. Key Highlights
10.1.1.1. Intermittent Catheter
10.1.1.2. Indwelling (Foley) Catheter
10.1.1.3. External Catheter
10.2. Middle East & Africa Urinary Catheters Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.2.1. Key Highlights
10.2.1.1. Urinary Incontinence
10.2.1.2. Urinary Retention
10.2.1.3. Prostate Gland Surgery
10.2.1.4. Spinal Cord Surgery
10.2.1.5. Others
10.3. Middle East & Africa Urinary Catheters Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.3.1. Key Highlights
10.3.1.1. GCC Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.3.1.2. GCC Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.3.1.3. South Africa Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.3.1.4. South Africa Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.3.1.5. Egypt Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.3.1.6. Egypt Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.3.1.7. Nigeria Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.3.1.8. Nigeria Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.3.1.9. Rest of Middle East & Africa Urinary Catheters Market by Product, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.3.1.10. Rest of Middle East & Africa Urinary Catheters Market Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2030
10.3.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Product vs Application Heatmap
11.2. Manufacturer vs Application Heatmap
11.3. Company Market Share Analysis, 2024
11.4. Competitive Dashboard
11.5. Company Profiles
11.5.1. B. Braun Melsungen AG
11.5.1.1. Company Overview
11.5.1.2. Product Portfolio
11.5.1.3. Financial Overview
11.5.1.4. Business Strategies and Development
11.5.2. Coloplast A/S
11.5.2.1. Company Overview
11.5.2.2. Product Portfolio
11.5.2.3. Financial Overview
11.5.2.4. Business Strategies and Development
11.5.3. Becton, Dickinson, and Company
11.5.3.1. Company Overview
11.5.3.2. Product Portfolio
11.5.3.3. Financial Overview
11.5.3.4. Business Strategies and Development
11.5.4. Teleflex Incorporation
11.5.4.1. Company Overview
11.5.4.2. Product Portfolio
11.5.4.3. Financial Overview
11.5.4.4. Business Strategies and Development
11.5.5. Boston Scientific Corporation
11.5.5.1. Company Overview
11.5.5.2. Product Portfolio
11.5.5.3. Financial Overview
11.5.5.4. Business Strategies and Development
11.5.6. Medtronic Plc.
11.5.6.1. Company Overview
11.5.6.2. Product Portfolio
11.5.6.3. Financial Overview
11.5.6.4. Business Strategies and Development
11.5.7. Hollister Incorporate
11.5.7.1. Company Overview
11.5.7.2. Product Portfolio
11.5.7.3. Financial Overview
11.5.7.4. Business Strategies and Development
11.5.8. BIOTRONIK SE & CO. KG
11.5.8.1. Company Overview
11.5.8.2. Product Portfolio
11.5.8.3. Financial Overview
11.5.8.4. Business Strategies and Development
11.5.9. Cook Medical
11.5.9.1. Company Overview
11.5.9.2. Product Portfolio
11.5.9.3. Financial Overview
11.5.9.4. Business Strategies and Development
11.5.10. Cathetrix
11.5.10.1. Company Overview
11.5.10.2. Product Portfolio
11.5.10.3. Financial Overview
11.5.10.4. Business Strategies and Development
11.5.11. UroDev Medical
11.5.11.1. Company Overview
11.5.11.2. Product Portfolio
11.5.11.3. Financial Overview
11.5.11.4. Business Strategies and Development
11.5.12. Stryker Corporation
11.5.12.1. Company Overview
11.5.12.2. Product Portfolio
11.5.12.3. Financial Overview
11.5.12.4. Business Strategies and Development
11.5.13. Consure Medical
11.5.13.1. Company Overview
11.5.13.2. Product Portfolio
11.5.13.3. Financial Overview
11.5.13.4. Business Strategies and Development
11.5.14. J and M Urinary Catheters LLC
11.5.14.1. Company Overview
11.5.14.2. Product Portfolio
11.5.14.3. Financial Overview
11.5.14.4. Business Strategies and Development
11.5.15. Urocare Products Inc.
11.5.15.1. Company Overview
11.5.15.2. Product Portfolio
11.5.15.3. Financial Overview
11.5.15.4. Business Strategies and Development
11.5.16. Wellspect Healthcare
11.5.16.1. Company Overview
11.5.16.2. Product Portfolio
11.5.16.3. Financial Overview
11.5.16.4. Business Strategies and Development
11.5.17. CompactCath
11.5.17.1. Company Overview
11.5.17.2. Product Portfolio
11.5.17.3. Financial Overview
11.5.17.4. Business Strategies and Development
11.5.18. ConvaTec
11.5.18.1. Company Overview
11.5.18.2. Product Portfolio
11.5.18.3. Financial Overview
11.5.18.4. Business Strategies and Development
11.5.19. Cardinal Health, Inc.
11.5.19.1. Company Overview
11.5.19.2. Product Portfolio
11.5.19.3. Financial Overview
11.5.19.4. Business Strategies and Development
11.5.20. Amsino International Inc.
11.5.20.1. Company Overview
11.5.20.2. Product Portfolio
11.5.20.3. Financial Overview
11.5.20.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations
BASE YEAR |
HISTORICAL DATA |
FORECAST PERIOD |
UNITS |
|||
2023 |
2019 - 2023 |
2024 - 2031 |
Value: US$ Billion |
REPORT FEATURES |
DETAILS |
Product Type Coverage |
|
Application Coverage |
|
Geographical Coverage |
|
Leading Companies |
|
Report Highlights |
Key Market Indicators, Macro-micro economic impact analysis, Technological Roadmap, Key Trends, Driver, Restraints, and Future Opportunities & Revenue Pockets, Porter’s 5 Forces Analysis, Historical Trend (2019-2021), Market Estimates and Forecast, Market Dynamics, Industry Trends, Competition Landscape, Category, Region, Country-wise Trends & Analysis, COVID-19 Impact Analysis (Demand and Supply Chain) |
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.
View Methodology